학술논문

Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2019, 37 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755